A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OLK / oral leukoplakia

[Related PubMed/MEDLINE]
Total Number of Papers: 64
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OLK  (>> Co-occurring Abbreviation)
Long Form:   oral leukoplakia
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Acetaldehyde production by Rothia mucilaginosa isolates from patients with oral leukoplakia. AcH, ALDH
2020 Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. aHR
2020 DEC1: a potential biomarker of malignant transformation in oral leukoplakia. H-OLK, NM, OPMDs, OSCC
2019 CDK4, CDK6, cyclin D1 and Notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer. OLBC, OSCC
2019 Changes in oral microbial profiles associated with oral squamous cell carcinoma vs leukoplakia. HC, OSCC
2019 Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation. DSB, FA, OSCC, sPLS-DA
2019 Expression and Significance of Periostin in Tissues and Serum in Oral Leukoplakia and Squamous Cell Carcinoma. OSCC
2019 Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes. DFS, OPMDs, OS, OSCC, PD-L1
2019 Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma. HPV, IHC, OSCC, PCR
10  2019 Long-term cigarette smoking suppresses NLRP3 inflammasome activation in oral mucosal epithelium and attenuates host defense against Candida albicans in a rat model. C. albicans, CS, NLRP3
11  2019 Malignant transformation of oral leukoplakia treated with carbon dioxide laser: a meta-analysis. CI, OR
12  2019 Malignant transformation rate of oral leukoplakia in an Australian population. MT, OED, OSCC, TMT
13  2019 Oral submucous fibrosis: A clinicopathological study of 674 cases in China. OSF
14  2019 Photodynamic therapy in the treatment of oral leukoplakia: A systematic review. PDT
15  2019 Plum-blossom needle assisted photodynamic therapy for the treatment of oral potentially malignant disorder in the elderly. ALA-PDT, OPMD, PBN
16  2019 Proteome profiling to identify peroxiredoxin 1 interacting protein partners in nicotine-associated oral leukoplakia. 4NQO, ASK1, Co-IP, DOK, OSCC, Prx1, ROS, Trx
17  2019 Risk Factors Associated With Malignant Transformation in Patients With Oral Leukoplakia in a Chinese Population: A Retrospective Study. OCFS
18  2019 Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. HPV, IHC, PCR
19  2019 [Clinical significance of microtubule-associated protein 1 light chain 3 and mammalian target of rapamycin expression in oral leukoplakia in smokers and never-smokers]. mTOR
20  2019 [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders]. OLP, OPMDs, OSCC, TIS, YI
21  2018 A three miRNAs signature for predicting the transformation of oral leukoplakia to oral squamous cell carcinoma. GEO, GO, miRNAs, OLK-OSCC, OSCC
22  2018 CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma. CD, LR-OLK, NOM, OSCC
23  2018 CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma. OSCC
24  2018 Overexpression of ADAM10 in oral squamous cell carcinoma with metastases. OSCC
25  2018 Regulation of proliferation and cell cycle by protein regulator of cytokinesis 1 in oral squamous cell carcinoma. OSCC, PRC1
26  2018 T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report. OSCC
27  2018 [Clinical importance of microtubule-associated protein 1 light chain 3 and mammalian target of rapamycin expression in oral leukoplakia and oral squamous cell carcinoma]. LC3, mTOR, OSCC
28  2018 [Comparative analysis of methylation profiles in tissues of oral leukoplakia and oral squamous cell carcinoma]. GO, KEGG, OSCC
29  2017 The prognostic value of B7-H6 protein expression in human oral squamous cell carcinoma. ---
30  2016 Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study. DKK3, NOM, OSCC, OSF, TSG
31  2016 Association of Decreased Expression of Serum miR-9 with Poor Prognosis of Oral Squamous Cell Carcinoma Patients. OSCC, qRT-PCR
32  2016 Associations Among Glutathione S-Transferase T1, M1, and P1 Polymorphisms and the Risk of Oral Leukoplakia. CNKI, GST, GSTM1, GSTP1, GSTT1, ORs
33  2016 DJ-1 Is Upregulated in Oral Squamous Cell Carcinoma and Promotes Oral Cancer Cell Proliferation and Invasion. OSCC
34  2016 Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma. IL-37, NC, OSCC
35  2016 Peroxiredoxin 1 has an anti-apoptotic role via apoptosis signal-regulating kinase 1 and p38 activation in mouse models with oral precancerous lesions. 4NQO, ASK1, Prx1
36  2016 Signal regulatory protein alpha associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages. OSCC, PDTC, SIRPalpha
37  2016 [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma]. HPV, ISH, OED, OLP, OSCC
38  2016 [Epidemiological investigation of chewing fresh or dried betel nut and oral mucosal disease]. OLP, OSF
39  2015 Analysis of plasma metabolic biomarkers in the development of 4-nitroquinoline-1-oxide-induced oral carcinogenesis in rats. 4NQO, ANOVA, NMR, OSCC, PCA, PLS-DA, VIP
40  2015 Establishment of a new OSCC cell line derived from OLK and identification of malignant transformation-related proteins by differential proteomics approach. OSCC
41  2015 Fourier-transform-infrared-spectroscopy based spectral-biomarker selection towards optimum diagnostic differentiation of oral leukoplakia and cancer. DBMS, FFS, FTIR, NOM, OSCC, SVM
42  2015 Identification of Gene and MicroRNA Signatures for Oral Cancer Developed from Oral Leukoplakia. miRNAs
43  2015 MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia. GEO, GO, KEGG, miRNA
44  2015 Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia. ASK1, mRNA, p-ASK1, Prx1
45  2015 Quantitative risk stratification of oral leukoplakia with exfoliative cytology. EdTAR, OCRI, OSCC, SVM
46  2015 [Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance]. ---
47  2014 NOD1, RIP2 and Caspase12 are potentially novel biomarkers for oral squamous cell carcinoma development and progression. hBD1, 2, 3, NOD1, OSCC, RIP2
48  2012 Expressions of CXCL12/CXCR4 in oral premalignant and malignant lesions. OSCC
49  2012 Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia. FGF3, FISH, mtOLK
50  2011 A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK. OSCC, SVM
51  2011 Expressions of CXCR7/ligands may be involved in oral carcinogenesis. OSCC
52  2011 Identification of genes related to carcinogenesis of oral leukoplakia by oligo cancer microarray analysis. OSCC, RT-PCR
53  2011 Salivary metabolite signatures of oral cancer and leukoplakia. OSCC
54  2011 [A retrospective analysis on the malignant transformation rate, time and risk factors of oral leukoplakia]. MTR, MTT
55  2011 [Correlation between the quantity of oral mucosal micronucleus cells and cancerization]. OED, OLP, OSCC
56  2010 [Near infrared Raman spectral character and diagnostic value of squamous cell carcinoma of oral mucosa]. OSCC
57  2009 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma. OSCC, PCA, PLS-DA
58  2009 Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK. LCM, OSCC
59  2009 Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia. Ig, rAd
60  2009 [Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions]. NOM, OLP, OSCC, RIP
61  2008 A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia. HPCA, OLP, OSCC
62  2007 [Amplification methods of DNA from paraffin-embedded tissues of oral leukoplakia]. ---
63  2005 [Amplification of EMS1 gene in oral carcinogenesis]. OSCC
64  2003 [The age-related changes of P53 protein expression in oral mucosa and their effects on oral leukoplakia]. ---